RESEARCH ARTICLE


Fibromyalgia Concomitant with Seropositive Rheumatoid Arthritis in a Tertiary Hospital in South-Western Saudi Arabia: Prevalence and Treatment Patterns



Mohammed AlOmair1, *, Hanan AlMalki1, #, Leen Sarhan1, Mohammed Shweel1, Abdulrahman Asiri1, Eman Almhjani1, Alhussain Asiri1, Hanan AlQahtani1, Aydah Rahman1, Esraa Hasan1
1 Division of Rheumatology, Department of Medicine, Asir Central Hospital, Abha, Saudi Arabia


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 274
Abstract HTML Views: 249
PDF Downloads: 160
ePub Downloads: 107
Total Views/Downloads: 790
Unique Statistics:

Full-Text HTML Views: 194
Abstract HTML Views: 117
PDF Downloads: 131
ePub Downloads: 88
Total Views/Downloads: 530



Creative Commons License
© 2022 AlOmair et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Division of Rheumatology, Department of Medicine, Asir Central Hospital, P.O. Box 34, Abha, Saudi Arabia; Fax: 00966172243595, E-mails: alomair.mohd@gmail.com, MAL-OMAIR@moh.gov.sa


Abstract

Introduction:

Rheumatoid arthritis (RA) patients with fibromyalgia syndrome (FMS) report worse functional status and quality of life hence the association has important clinical implications. FMS can be challenging to treat, and the current evidence recommends a multidisciplinary treatment approach focused on symptom management.

Aim:

Information regarding the current prevalence of FMS in RA patients is lacking. Thus, this study aims to address the prevalence and predictors of FMS in seropositive RA patients and demonstrate our clinical practice in the management of FMS.

Methods:

Participants’ data was gathered from Aseer central hospital (ACH) rheumatology clinics and daycare units over a period of 2 years. Subjects were assessed using the 2010 American College of Rheumatology (ACR) criteria for FMS. Data were collected from medical records, including patient demographics, comorbidities and concomitant FMS-related data.

Results:

Out of 310 seropositive RA patients, 15% (n = 47) fulfilled the diagnostic criteria for FMS. Of them, 29, 11 and 7 were on pregabalin, amitriptyline and duloxetine, respectively. Half of FMS patients showed one or more therapy changes. A significant difference between RA patients with and without concomitant FMS was observed, including age, gender and comorbidities.

Conclusion:

In this retrospective study, a high prevalence of FMS in individuals with seropositive RA was identified. This study explores real-world practice in the treatment of FMS with remarkable findings regarding underdosing and lower discontinuation rate of pregabalin.

Keywords: Fibromyalgia, Rheumatoid arthritis, Prevalence, Duloxetine, Pregabalin, Amitriptyline.